electroCore, Inc. (ECOR) vs Pulmonx Corporation (LUNG)
electroCore, Inc. and Pulmonx Corporation are both Medical Devices companies. electroCore, Inc. is the larger, with a market value of $102.3M against $81.6M — 1.3× the size. electroCore, Inc. grew revenue faster over the last twelve months: 33.5% against −3.43%. electroCore, Inc. has the higher net margin (−40.0% vs −55.0%) and the higher return on invested capital (0.00% vs −141.0%). Across the 17 metrics below, electroCore, Inc. leads on 12 and Pulmonx Corporation on 5.
Valuation
Profitability
| Metric | ECOR | LUNG | Medical Devices median |
|---|---|---|---|
| Gross margin | 87.06% | 77.06% | 56.01% |
| Operating margin | (37.64%) | (52.96%) | (15.03%) |
| Net margin | (39.96%) | (55.03%) | (20.40%) |
| Free cash flow margin | (26.36%) | (35.07%) | (7.24%) |
| Return on equity | 1,761.48% | (88.87%) | (15.32%) |
| Return on assets | (93.41%) | (36.74%) | (19.72%) |
| Return on invested capital | 0.00% | (141.03%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack